Cla4 phosphorylates histone methyltransferase Set1 to prevent its degradation by the APC/C<sup>Cdh1</sup> complex.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37774018.
- Also identified by DOI 10.1126/sciadv.adi7238 and PMC identifier 10541012.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
H3K4 trimethylation (H3K4me3) is a conserved histone modification catalyzed by histone methyltransferase Set1, and its dysregulation is associated with pathologies. Here, we show that Set1 is intrinsically unstable and elucidate how its protein levels are controlled within cell cycle and during gene transcription. Specifically, Set1 contains a destruction box (D-box) that is recognized by E3 ligase APC/C<sup>Cdh1</sup> and degraded by the ubiquitin-proteasome pathway. Cla4 phosphorylates serine 228 (S228) within Set1 D-box, which inhibits APC/C<sup>Cdh1</sup>-mediated Set1 proteolysis. During gene transcription, PAF complex facilitates Cla4 to phosphorylate Set1-S228 and protect chromatin-bound Set1 from degradation. By modulating Set1 stability and its binding to chromatin, Cla4 and APC/C<sup>Cdh1</sup> control H3K4me3 levels, which then regulate gene transcription, cell cycle progression, and chronological aging. In addition, there are 141 proteins containing the D-box that can be potentially phosphorylated by Cla4 to prevent their degradation by APC/C<sup>Cdh1</sup>. We addressed the long-standing question about how Set1 stability is controlled and uncovered a new mechanism to regulate protein stability.
Medical subject headings
- Cell Cycle Proteins
- Saccharomyces cerevisiae Proteins